Informal Consultation on the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property

Summary report

Overview

In response to World Health Assembly decision WHA73(11), the Director-General convened an informal consultation of Member States on the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property (GSPA-PHI) on 3 December 2020 to discuss the recommendations of the review panel referred to in paragraph 2 of decision WHA71(9) (2018) as “not emanating from the global strategy and plan of action on public health, innovation and intellectual property” and the “recommendations of the review panel on promoting and monitoring transparency of medicines prices and actions to prevent shortages” referred to in paragraph 3 of decision WHA73(11).

 

WHO Team
Medicines Selection, IP and Affordability (MIA)
Number of pages
5